LGMay 15, 2015

A Multivariate Biomarker for Parkinson's Disease

arXiv:1602.07264v11 citations
Originality Incremental advance
AI Analysis

This addresses the need for reliable biomarkers in Parkinson's disease diagnosis, but it appears incremental as it builds on existing genomic analysis with a multivariate approach.

The study tackled the problem of detecting and classifying Parkinson's disease samples by identifying a multivariate biomarker, resulting in a group of 20 genes that showed clear potential for accurate classification even in the presence of other neurodegenerative disorders.

In this study, we executed a genomic analysis with the objective of selecting a set of genes (possibly small) that would help in the detection and classification of samples from patients affected by Parkinson Disease. We performed a complete data analysis and during the exploratory phase, we selected a list of differentially expressed genes. Despite their association with the diseased state, we could not use them as a biomarker tool. Therefore, our research was extended to include a multivariate analysis approach resulting in the identification and selection of a group of 20 genes that showed a clear potential in detecting and correctly classify Parkinson Disease samples even in the presence of other neurodegenerative disorders.

Foundations

The foundational work for this paper's niche, ranked by how specifically the neighbourhood builds on it — not by global fame.

Your Notes